Table 2.
Demographic and clinical characteristics, comorbodity conditions, complications of 70 BAV and 70 TAV subjects.
| Variables | BAV N = 70 | TAV N = 70 | P | |
|---|---|---|---|---|
| Demographic characteristics | Age, mean (SD) | 58.8 (14.8) | 69.1(12.8) | <0.0001 |
| Male sex, No. (%)* | 50 (71) | 35(50) | 0.009 | |
| Female sex, No. (%) | 20 (29) | 35 (50) | 0.009 | |
| Body mass index, mean (SD) | 26 (4.8) | 26.3 (3.2) | N.S. | |
| Size and location of AAA | Subjects affected (%) | 51 (73) | 25(36) | 0.00001 |
| Size (mm), mean (SD) | 53.3 (7.4) | 50.3 (6.9) | N.S. | |
| Location, No: | ||||
| Tubular ascending aorta | 51 (100) | 25 (100) | N.S. | |
| Comorbidity conditions, No (%) | CVD Family History | 8 (11) | 5 (7.1) | N.S. |
| Smoking | 26 (37) | 20 (28) | N.S. | |
| Hypertension | 55 (78) | 50 (719 | N.S. | |
| Dyslipidemia | 9 (13) | 5 (7.1) | N.S. | |
| Diabetes mellitus | 3 (4.2) | 1 (1.4) | N.S. | |
| Renal failure | 0 (0) | 1 (1.4) | N.S. | |
| Dissection | 0 (0) | 0 (0) | N.S. | |
| Aortic valve pathology, No (%): | ||||
| Normal | 0 (0) | 38 (54) | 0.0001 | |
| Prolapse | 8 (11) | 0(0) | 0.003 | |
| Vascular calcium fibrosis | 35 (50) | 7 (10) | 2.4e-7 | |
| Atherosclerosis coronary syndrome, No (%): | 2 (3) | 1 (0.8) | N.S. | |
*Percentage values on total BAV and TAV subjects.
P = TAV vs. BAV, by t Student test for quantitative variables, or χ2 test for qualitative variables.